More lab tests than at your doctor’s office

Learn more

What Are Biomarkers? A Guide to Understanding the Health Indicators

Dr. Felix Gussone

Reviewed by Felix Gussone, MD

Written by Lauren Panoff

Published 10/30/2025

Key Takeaways: 

  • Biomarkers — aka biological markers — are measurable indicators of health that can detect disease, monitor treatment, and guide preventive care.

  • Types of biomarkers vary by purpose, including diagnosis or risk assessment.

  • For men, common biomarkers include cholesterol, hemoglobin A1C (HbA1c), prostate-specific antigen (PSA), testosterone, and C-reactive protein (CRP), which together provide valuable health insights. 

  • Biomarkers are most useful when interpreted with medical guidance and used alongside other assessment tools.

     


Biomarkers, or biological markers, are essentially your body’s health signals. They’re measurable indicators of what’s happening beneath the surface of your body, and they can often provide insight before you notice any symptoms in your day-to-day life. 

These biological clues play a critical role in understanding, diagnosing, and managing men's health conditions. For example, cholesterol levels help estimate cardiovascular risk, and blood sugar markers such as HbA1c track diabetes risk and control.

Monitoring specific biomarkers with blood tests can help provide a clearer picture of overall health and help detect disease early. These data points also guide personalized treatment decisions that can protect your long-term health outcomes and normal biological processes.

Biomarkers are measurable signs of what’s happening inside your body. Think of them as health “checkpoints” that can show whether your systems are working appropriately, if a disease is developing, or how well a treatment is working. 

Cholesterol, blood sugar, and blood pressure (also considered a physiologic measurement) levels are common examples of biomarkers that give notable clues about your overall health.

Biomarkers can be found in blood, urine, saliva, tissues, or even imaging scans. Capturing certain biomarkers is as simple as a lab test you get during an annual physical. Others are highly specialized, like genetic markers that guide cancer treatment. 

Because biomarkers reliably reflect biological changes, the metrics are among the most widely used tools healthcare providers rely on to track wellness over time and personalize treatment plans.

Biomarkers provide a window into your health that goes beyond how you feel on the surface. They help protect your health and biological systems by making prevention, diagnosis, and treatment more precise.

Many conditions, like high cholesterol, diabetes, or even certain cancers, can develop silently for years before symptoms appear. Biomarkers may illuminate early signals, sometimes providing the opportunity to take action before underlying problems become serious.

Biomarkers are also key in guiding treatment. For example, if you’re taking medication for high blood pressure or cholesterol, regular checks can show whether the treatment is working or if adjustments are needed. 

In research and personalized medicine, lab biomarkers help match people with therapies that are most likely to work for their specific biology.

Biomarkers fall into different categories depending on what they measure and how they’re used. Here are seven types:

Diagnostic Biomarkers

These help confirm whether a disease or condition is present. 

For example, elevated troponin levels in the blood are a key diagnostic biomarker for heart attacks; elevated PSA can indicate—but does not diagnose—prostate cancer, and chronically high CRP may be associated with inflammatory diseases, like cardiovascular disease or rheumatoid arthritis.

Prognostic Biomarkers

These provide information about how a disease may progress. Certain genetic markers in cancer, for instance, can predict whether the disease is likely to spread or remain stable. 

Predictive Biomarkers

These biomarkers indicate how likely someone is to respond to a specific treatment. 

One example is HER2/neu status in breast cancer, which guides the use of targeted therapies. Individuals who are HER2/neu positive may benefit from earlier treatment with trastuzumab medication.

Monitoring Biomarkers

These track the effectiveness or safety of a treatment over time. 

For example, HbA1c is commonly used to monitor long-term blood sugar control in people with diabetes. Whether it increases, decreases, or remains stable can indicate the effectiveness of diabetes treatment or the progression of insulin resistance. 

Pharmacodynamic or Response Biomarkers

These biomarkers show the biological response to a treatment and are often used in clinical trials to assess the effectiveness of new treatments. 

Two examples of response biomarkers include changes in tumor size during chemotherapy and changes in high-sensitivity CRP and LDL (low-density lipoprotein) cholesterol levels after starting statins.

Susceptibility or Risk Biomarkers

These biomarkers identify the likelihood of developing a disease in the future. High LDL cholesterol is a classic example, as it signals increased risk for cardiovascular disease. 

BRCA1 and BRCA2 genetic mutations are also examples. They indicate a higher lifetime risk of breast and ovarian cancer in women and increased prostate cancer risk in men.

Safety Biomarkers

Safety biomarkers suggest the likelihood, presence, or extent of toxicity resulting from exposure to a treatment or environmental agent. 

Liver function tests, for example, can detect drug-induced liver injury from using certain medications. 

Learn more about the different types in our guide about biomarker testing.

There are thousands of biomarkers, but some are especially important for monitoring men’s health. These key players include:

  • Cholesterol panel (LDL, HDL, triglycerides). Measures different types of fat in the blood. High LDL raises heart disease risk, while higher HDL is protective (to an extent).

  • Blood glucose and hemoglobin A1C (HbA1c). Reflects average blood sugar levels over the past three months and helps assess diabetes risk or management. Levels ≥ 6.5 percent confirm diabetes, while 5.7–6.4 percent indicate prediabetes.

  • Prostate-specific antigen (PSA). A protein that the prostate produces. Elevated levels can signal prostate enlargement, infection, or prostate cancer. Because PSA isn’t specific, providers interpret results alongside risk factors and symptoms.

  • Testosterone. Measures levels of the primary male sex hormone. Low levels may affect energy, mood, sexual health, and muscle mass. Diagnosis of low T requires both consistent symptoms and two morning tests below 300 nanograms per deciliter (ng/dL).

  • C-reactive protein (CRP). An inflammatory marker that may indicate increased cardiovascular risk when elevated persistently, and should be interpreted in context.

  • Blood pressure. Though not a lab test, it’s a simple and powerful biomarker for heart and kidney health.

  • Vitamin D levels. Low levels are common and may impact bone strength, immunity, and mood.

Together, these biomarkers provide a snapshot of overall health. The measurements can help men and their providers catch issues early, at the most treatable point. 

One of the biggest advantages of using biomarkers to guide medical diagnosis and treatment is that the metrics support personalized treatment plans, alongside symptoms, history, and exam findings. These are healthcare plans tailored to an individual’s unique biology. 

Instead of relying only on one-size-fits-all treatments, doctors can use biomarkers to determine which therapies are most likely to work for a specific person. 

For example, in cancer care, genetic biomarkers can indicate whether a tumor is likely to respond to targeted therapies or immunotherapy. In cardiology, cholesterol and inflammatory biomarkers can guide decisions about preventive medications. And in mental health, researchers are studying biomarkers that could predict how someone might respond to antidepressants (no biomarker is yet routinely used to predict antidepressant response in everyday care)

This precision-oriented approach could mean fewer trial-and-error treatments, faster results, and a greater chance of long-term success.  

As science advances, emerging biomarkers are expected to further improve early detection and customized care for cancer, heart disease, autoimmune disorders, and nervous system–related conditions. 

While biomarkers are insightful tools, they’re not perfect.  

A single biomarker result usually can’t provide a complete picture of health. It needs to be interpreted alongside symptoms, medical history, and other test results. For example, an elevated PSA level doesn’t always mean prostate cancer. Infection or an enlarged prostate could be the root cause. Similarly, elevated CRP may reflect infection, inflammation, or recent injury. It does not necessarily mean heart disease. 

Biomarkers can also vary based on age, lifestyle, or even temporary factors like stress, what you’ve been eating, and whether you’re fighting an infection. This means results sometimes lead to false alarms or unnecessary testing.  

Additionally, not every condition connects with a reliable biomarker. Specifically, research is catching up to establish new biomarkers for areas like mental health and neurodegenerative diseases.

Overall, biomarkers are extremely valuable, but as is true for most health tools, they’re most effective when used as part of a broader assessment guided by a qualified healthcare provider. 

Biomarkers are health signals from your body. They can provide essential information about what’s happening before symptoms appear. 

They’re particularly helpful for guiding early diagnosis and personalized treatment. Tracking key biomarkers offers men a proactive way to protect their health, manage risk, and make smarter care decisions.

Here are some answers to commonly asked questions about biomarkers for men’s health, including what they are and why they matter.

Are biomarkers the same as lab tests?

Not exactly. Biomarkers are the indicators that lab tests measure. In other words, lab tests are how we check biomarkers.

Can lifestyle changes improve biomarkers?

Often, yes. Lifestyle medicine is a powerful therapeutic intervention for optimizing your health. Nutrition, exercise, sleep, and stress management can positively influence biomarkers, like cholesterol, blood pressure, blood sugar, and inflammation. That’s why many biomarkers are useful for tracking progress over time.

Do biomarkers change with age?

They can. For example, testosterone levels naturally decline as men get older, while cholesterol and blood pressure often rise with age. Regular monitoring helps spot what’s a normal change over time versus a red flag.

How often should men get biomarker tests?

The cadence of testing depends on age, health history, and risk factors. For most adults, providers recommend regular screening of many biomarkers, including lipid panels, blood sugar, and blood pressure, or more frequent testing if there are health concerns.

20 Sources

  1. Abdulla A, et al. (2024). Biomarker Assays for Elevated Prostate-Specific Antigen Risk Analysis. https://pubmed.ncbi.nlm.nih.gov/37276301/
  2. Buoli M, et al. (2025). Biomarkers associated with antidepressant response and illness severity in major depressive disorder: a pilot study. https://pubmed.ncbi.nlm.nih.gov/40445583/
  3. Califf RM. (2018). Biomarker definitions and their applications. https://pmc.ncbi.nlm.nih.gov/articles/PMC5813875/
  4. Castellani G, et al.(2023). BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. https://pubmed.ncbi.nlm.nih.gov/37627054/
  5. Castro-Guijarro AC, et al. (2023). Potential Biomarkers Associated with Prognosis and Trastuzumab Response in HER2+ Breast Cancer. https://pubmed.ncbi.nlm.nih.gov/37686651/
  6. Centers for Disease Control and Prevention. (2024). About Cholesterol. https://www.cdc.gov/cholesterol/about/index.html
  7. Chia JE, et al. (2025). Elevated C-reactive protein and cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/40014057/
  8. Cui A, et al. (2023). Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. https://pubmed.ncbi.nlm.nih.gov/37006940/
  9. De Bhailis ÁM, et al. (2022). Hypertension and the kidneys. https://pubmed.ncbi.nlm.nih.gov/35653320/
  10. Franczyk B, et al. (2021). Is a High HDL-Cholesterol Level Always Beneficial?. https://pmc.ncbi.nlm.nih.gov/articles/PMC8466913/
  11. Grisham J. Memorial Sloan Kettering Cancer Center. (2024). Myths About PSA Tests and Prostate Cancer Screening. https://www.mskcc.org/news/myths-about-psa-tests-and-prostate-cancer-screening
  12. Hosack T, et al. (2023). Drug-induced liver injury: a comprehensive review. https://pmc.ncbi.nlm.nih.gov/articles/PMC10031606/
  13. Khalizieva A, et al. (2025). BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality. https://pubmed.ncbi.nlm.nih.gov/39510841/
  14. Park SE, et al. (2015). Biomarkers of insulin sensitivity and insulin resistance: Past, present and future. https://pubmed.ncbi.nlm.nih.gov/26042993/
  15. Phillips EM, et al. (2020). Lifestyle Medicine. https://pubmed.ncbi.nlm.nih.gov/32981575/
  16. Pope JE, et al. (2021). C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. https://pubmed.ncbi.nlm.nih.gov/33385862/
  17. Potter JM, et al. (2022). Troponins in myocardial infarction and injury. https://pmc.ncbi.nlm.nih.gov/articles/PMC9081942/
  18. Ridker P, et al. (2023). Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2900215-5/abstract
  19. Shamshirian A, et al. (2020). Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC7603697/
  20. Strimbu K, et al. (2010). What are biomarkers?. https://pmc.ncbi.nlm.nih.gov/articles/PMC3078627/
Editorial Standards

Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!

This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.

Felix Gussone, MD

Education

Other Certificates & Certifications

Specialties & Areas of Focus

  • General Practice

Previous Work Experience

  • Manager, Medical Content & Education - Ro, 2021–2024 

  • Senior Health Editor - Medium, 2019–2021

  • Associate Medical Producer - NBC News, 2015–2019

  • Production Assistant - CNN, 2015

Media Mentions & Features

Why I Practice Medicine

  • Dr. Gussone discovered his passion for creating medical content and educating the public about health while working with CNN’s Dr. Sanjay Gupta. He realized that the media could deliver essential health information to millions, surpassing the reach of one-on-one care in a clinical setting.

Hobbies & Interests

  • Scuba diving, traveling, cinema, and perfume making

LinkedIn

Read more